Skip to main content
. Author manuscript; available in PMC: 2017 Dec 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):572–580. doi: 10.1097/QAI.0000000000001145

Table 2. Percentage of mothers with detectable maternal HIV RNA by study arm, week postpartum, and infant's 28 week HIV-infection status.*.

Maternal ARV arm Infant NVP arm
Total mothers tested Detectable plasma HIV RNA Total mothers tested Detectable breastmilk HIV RNA Total mothers tested Detectable plasma HIV RNA Total mothers tested Detectable breastmilk HIV RNA
N n (%) N n (%) N n (%) N n (%)
HIV-transmitting mothers
  2 weeks 8 7 (88) 13 2 (15) 6 6 (100) 6 1 (17)
  4 weeks -- -- -- 11 3 (27) -- -- -- 6 3 (50)
  6 weeks 15 15 (100) 9 3 (33) 8 8 (100) 5 3 (60)
  8 weeks -- -- -- 8 2 (25) -- -- -- 6 4 (67)
 12 weeks 12 11 (92) 7 3 (43) 8 8 (100) 6 5 (83)
 18 weeks 4 4 (100) 5 3 (60) 1 1 (100) 4 2 (50)
 24 weeks 9 8 (89) 3 1 (33) 8 8 (100) 3 2 (67)
 Overall median log10 copies/ml (IQR) 3.9 (2.3-4.7) 1.7 (1.7-2.1) 4.1 (3.4-4.8) 1.9 (1.7-2.7)
Non-transmitting mothers
  2 weeks 74 63 (85) 90 14 (16) 82 78 (95) 101 15 (15)
  4 weeks -- -- -- 87 15 (17) -- -- -- 106 38 (36)
  6 weeks 97 71 (73) 89 9 (10) 111 108 (97) 96 50 (52)
  8 weeks -- -- -- 91 7 (8) -- -- -- 93 53 (57)
 12 weeks 93 51 (55) 85 12 (14) 105 105 (100) 92 45 (49)
 18 weeks 55 32 (58) 72 9 (13) 70 70 (100) 89 45 (51)
 24 weeks 71 39 (55) 62 9 (15) 92 92 (100) 78 40 (51)
 Overall median log10 copies/ml (IQR) 2.2 (1.6-3.2) 1.7 (1.7-1.7) 4.2 (3.2-4.9) 1.7 (1.7-2.4)
*

Plasma specimens were not collected at week 4 or week 8. Plasma HIV RNA concentrations ≥40 copies/ml and breastmilk HIV RNA concentrations ≥56 copies/ml were considered detectable